A trial of detecting impending access-graft failure by simplified weekly flow monitoring.
Access graft failure is a major problem in hemodialysis. Monitoring the flow through the access so that impending failure can be detected and prevented seems reasonable, but recent clinical trials have failed to show any benefit of such monitoring. Described here are plans for a clinical trial of a new flow monitoring procedure that measures access flow weekly instead of monthly and, being performed before dialysis, avoids the dialysis-induced changes in graft flow that may have affected earlier trials. The planned trial is to be carried out in two stages, the first to establish the sensitivity and specificity of the new method, and the second (if the results of the first stage warrant it) a controlled trial comparing access-costs and hospitalization days between a monitored group and a matched standard care control group. It is hoped that this trial of the new method will establish it as an effective means of extending access-graft life.
Vilkomerson
D
D
DVX, llc, Kingston, NJ 08528, USA. dvilkomerson@echocathinic.com
Chilipka
T
T
Rafi
H
H
Homel
P
P
Ghadari
G
G
Eisen
T
T
Finkelstein
F
F
Kuhlmann
M
M
Levin
N
N
D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D001783:Blood Flow Velocity; D002986:Clinical Trials as Topic; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging* / Q000209:etiology; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008991:Monitoring, Physiologic / Q000379:methods*; D011475:Prosthesis Failure; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D012680:Sensitivity and Specificity; D014463:Ultrasonography